linkedin.com/posts/activity…

Multiple sclerosis and the advent of biosimilar monoclonal antibodies: ANTELOPE shows that biosimilar natalizumab matched reference in efficacy, safety, and immunogenicity for patients with RRMS in the tested randomised controlled trial. lnkd.in/e8tPjqu3

Cerebrospinal fluid analysis is the way to better and more precisely diagnose, prognose and monitor neuropsychiatric disease manifestations. A milestone in making this an achievable goal: CSF cells can be shipped and analysed without loosing information (authors.elsevier.com/c/1gT~D52iy0rCi)

linkedin.com/posts/activity…

linkedin.com/posts/activity…

Learning pathogenesis of MS via therapeutic intervention (and thus applying the strategy of reverse and refined translation): a terrific example in neuroimmunology is anti-CD20 therapy….www.pnas.org/doi/10.1073/pnas.2221544120

Myasthenia gravis: die neuen Leitlinien für "Myasthene Syndrome" sind da. Neue Therapieoptionen ändern auch die Therapiekonzepte: das Ziel ist die bestmögliche Krankheitskontrolle (und die Herangehensweise auf Basis der Erkrankungsaktivität und -schwere). lnkd.in/eYgrjRn3

Leucocyte trafficking inhibition to modulate neuroinflammation: is MCAM a next generation target (and more clever than Natalizumab)? A commentary on novel findings and strategic thoughts around this: pubmed.ncbi.nlm.nih.gov/36946303/

Bruton Tyrosine Kinase inhibitors go strong in Multiple sclerosis: an unprecedented situation to have FOUR parallel programs already in Phase III. This review summarises why there is so much excitement and maybe promise for the field: pubmed.ncbi.nlm.nih.gov/37055617/

Due date for applications for the #WeAreNeuroimmunology Mid-Career Awards is May 30 2023 11:59 pm CET. #ISNI aims to recognize two candidates of the highest caliber in clinical and fundamental #neuroimmunology. APPLY now at: isniweb.org/we-are-neuroim…

ISNI officers strongly condemn the terrorist attack perpetrated by Hamas in Israel. We express our solidarity to all the civil populations of the area who suffer the consequences of unnecessary violence and to all our colleagues who are directly or indirectly involved.

Fresh data from trials of therapies that target immune #CellTrafficking—as well as biomaterial-based scientific projects—is helping to decode the biology of #MultipleSclerosis and other disorders of the central nervous system. Learn more: scim.ag/4Mz Heinz Wiendl

Finally: the German Myasthenia gravis guidelines now are released and published in english language and therefore are more globally readable and available! With the best wishes for a peaceful and conciliatory 2024! pubmed.ncbi.nlm.nih.gov/38152089/

Multiple sclerosis is a lot of different things. So, could there be distinct subtypes of the disease? A new study from Heinz Wiendl finds three — each with its own trajectory of illness. Could it help tailor treatments? A ditty from me: statnews.com/2024/03/27/mul…

Multiple sclerosis endophenotypes identified by high-dimensional blood signatures are associated with distinct disease trajectories | Science Translational Medicine science.org/doi/10.1126/sc…

SFB/CRC-TR 128 International Symposium: Multiple sclerosis and related disorders in 2024: Past, present, and future. April 29 and April 30 at Münster University (Schloss). #ms_symposium_2024 #MultipleSclerosis uni.ms/MSSymposium2024

#WEARENEUROIMMUNOLOGY #ISNI: Heinz Wiendl just had the pleasure of presenting the five hottest developments in neuroimmunology: clinical sciences at # EAN2024. Check out his list at isniweb.org #Neuroimmunology #MSResearch #MyastheniaGravis #NMOSD #MOGAD #Neurology

New Responsibility I am honored to announce that I will be taking on a new role as the Chair at the Klinik für Neurologie und Neurophysiologie at #UniversitätsklinikumFreiburg starting October 1, 2024. It is a privilege to join such a distinguished institution!

🚨 Paradigm shift in #MultipleSclerosis 🚨 New study in Nature Medicine shows MS is not fixed subtypes but a dynamic continuum of states across 4 dimensions: disability, brain damage, relapses & silent inflammation. 📖 Read: nature.com/articles/s4159… #MS #Neurology #AI

🚀 „KI ersetzt keine Ärztinnen oder Ärzte“ – mein Interview im Handelsblatt Handelsblatt über Prof. Valmed®: 🧠 CE-zertifizierte KI zur Unterstützung klinischer Entscheidungen ⚕️ Qualität & Sicherheit im Fokus 👉 Artikel: handelsblatt.com/technik/medizi…